Sellas Life Sciences (SLS) falls 0.3% to $11.31
SLS shares slipped 0.3% to $11.31, ending a two-week winning streak narrative with a third straight session of losses as leukemia research circulated ahead of Regal’s final-analysis milestone.
Shares of Sellas Life Sciences (SLS) were on track to break a two-week winning streak as new leukemia research rekindled retail optimism around its cancer vaccine ahead of Regal’s final-analysis milestone. 31, its third straight session of declines and l…